Voclosporin denied as not FDA-approved for this use by Aetna?

Aetna's specific coverage criteria for voclosporin are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna May Issue a "Not FDA-Approved" Denial for Voclosporin — and Why It Is Likely Erroneous

Voclosporin received FDA approval for its indicated use in adults with active lupus nephritis. If Aetna has issued a "not FDA-approved" denial, the most common explanations are: (1) the claim was coded in a way that suggested an off-label use; (2) the plan's system has an outdated formulary or policy file; or (3) the denial was issued in error and should be corrected through administrative appeal before any formal process.

This is one of the most straightforwardly reversible denial types — the FDA approval is a matter of public record.

## Immediate First Step

Before filing a formal appeal, call Aetna's pharmacy or clinical review line and ask a representative to confirm the current FDA approval status for voclosporin for lupus nephritis. Provide the FDA approval information from the prescribing label. Many denials of this type are reversed administratively within days.

## Your Formal Appeal Rights

• Internal appeal (ERISA §503 / ACA): File within the deadline on your denial letter. Attach the FDA-approved prescribing label as Exhibit A.
• External review (ACA §2719): If the internal appeal fails, you have approximately four months from the final internal denial to request binding independent external review. An IRO applying FDA records will almost certainly reverse a denial premised on a false factual premise.
• State insurance department complaint: If Aetna maintains the denial despite clear FDA approval documentation, a complaint to your state's insurance commissioner is appropriate. Regulators take factual errors on FDA status seriously.

## Documentation to Gather

1. FDA prescribing label — download the current label from the FDA's Drugs@FDA database; highlight the approved indication. 2. Diagnosis codes on the claim — confirm with your prescriber's billing office that the ICD-10 diagnosis code submitted matches the FDA-approved indication exactly. 3. Prescriber letter — a brief letter from the prescribing physician stating the patient's diagnosis, confirming it matches the approved indication, and noting that the drug is being prescribed within its FDA-approved labeling. 4. Prior authorization record — if a PA was submitted and approved at any prior point, include that approval as evidence of prior recognition.

## Criteria-Mapping Structure

| Denial Basis | Rebuttal Evidence | |---|---| | Drug not FDA-approved | FDA label (Drugs@FDA) confirming approval and indication | | Use outside approved indication | ICD-10 code matching label indication; prescriber attestation | | Outdated plan policy | Date-stamp on denial vs. FDA approval date |

Keep the appeal letter short and factual: state the approval, attach the label, and request immediate reversal.